Skip to main content
Clinical Trials/NL-OMON37417
NL-OMON37417
Completed
Not Applicable

The efficacy of pro- and anticoagulant therapy in plasma from patients with liver cirrhosis . - EPAC

niversitair Medisch Centrum Groningen0 sites126 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
coagulation.
Sponsor
niversitair Medisch Centrum Groningen
Enrollment
126
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Inclusion criteria study group:
  • \- Cirrhosis
  • \- \>18 year
  • \- Signed informed consent
  • Inclusion criteria healhty control group
  • \- \>18 year
  • \- Signed informed consent

Exclusion Criteria

  • Exclusion criteria study group:
  • \- Congenital coagulation disorder
  • \- Active infection
  • \- Acute liver failure
  • \- Use of anticoagulant drugs in the past 10 days
  • \- Pregnancy
  • \- (\<7 days) transfusion with blood products;Exclusion criteria control\-group
  • \- Documented history of congenital coagulation disorder
  • \- History of vascular disease
  • \- History of hepatic disease

Outcomes

Primary Outcomes

Not specified

Similar Trials